Zidovudine

What is Zidovudine?

Zidovudine, often referred to as AZT (azidothymidine), is a cornerstone antiretroviral medication used primarily in the management and prevention of HIV-1 infection. It belongs to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Zidovudine was historically significant as the first drug approved for the treatment of HIV/AIDS in 1987, marking a turning point in the fight against the epidemic. Its introduction significantly improved the prognosis for individuals living with HIV, transforming a previously fatal diagnosis into a manageable chronic condition. While newer, often better-tolerated drugs are now available, Zidovudine continues to play a vital role, particularly in specific treatment regimens and in the prevention of mother-to-child transmission of HIV.

How Does it Work?

Zidovudine exerts its therapeutic effect by interfering with the replication cycle of the Human Immunodeficiency Virus (HIV). As a nucleoside analogue, it mimics the natural building blocks of DNA. Once inside the body, Zidovudine is converted into its active triphosphate form. This active metabolite then competitively inhibits HIV-1 reverse transcriptase, an enzyme crucial for the virus to convert its RNA into DNA. By doing so, Zidovudine effectively terminates the viral DNA chain elongation, preventing the virus from replicating and infecting new cells. This action helps to reduce the viral load in the body, thereby slowing the progression of the disease and allowing the immune system to recover.

Medical Uses

The primary medical use of Zidovudine is in the treatment of HIV-1 infection in adults and children. It is almost always used as part of a combination antiretroviral therapy (cART) regimen, which typically includes two NRTIs plus a third active antiretroviral drug from a different class. This combination approach helps to achieve maximum viral suppression, reduce the risk of drug resistance, and improve patient outcomes.

Beyond direct treatment, Zidovudine is critically important for the prevention of mother-to-child transmission (PMTCT) of HIV. Administered to HIV-positive pregnant women and subsequently to their newborns, it significantly reduces the likelihood of the baby acquiring the virus. It is also used in post-exposure prophylaxis (PEP) regimens in certain situations, such as accidental occupational exposure to HIV (e.g., healthcare workers) or non-occupational exposure, to prevent infection if started quickly after exposure. By reducing the viral load, Zidovudine helps to protect the immune system, preventing the development of AIDS-defining conditions and opportunistic infections.

Dosage

The dosage of Zidovudine varies significantly based on the patient's age, weight, and the specific indication for which it is being used. For adults with HIV-1 infection, a common oral dosage is 300 mg twice daily, often in combination with other antiretroviral agents. For pediatric patients, the dosage is weight-based and carefully calculated by a healthcare professional.

In the context of preventing mother-to-child transmission, pregnant women with HIV may receive Zidovudine orally during pregnancy, intravenously during labor and delivery, and newborns are typically given an oral syrup for several weeks after birth. For post-exposure prophylaxis, Zidovudine is usually part of a multi-drug regimen initiated as soon as possible after exposure and continued for 28 days. It is crucial to adhere strictly to the prescribed dosage and schedule to ensure optimal efficacy and minimize the development of drug resistance. Zidovudine can be taken with or without food.

Side Effects

Like all medications, Zidovudine can cause side effects, some of which can be significant. Common side effects include nausea, vomiting, headache, malaise, insomnia, and asthenia (weakness). These are often mild to moderate and may improve over time.

More serious side effects associated with Zidovudine include:

• Bone Marrow Suppression: This is one of the most notable and potentially severe side effects, leading to anemia (low red blood cell count) and neutropenia (low white blood cell count). Regular blood tests are essential to monitor for these changes.
• Myopathy: Prolonged use can lead to muscle weakness and pain.
• Lactic Acidosis and Severe Hepatomegaly with Steatosis: Although rare, these are life-threatening conditions, characterized by an accumulation of lactic acid in the blood and an enlarged, fatty liver. Patients should be monitored for symptoms like persistent nausea, abdominal pain, and unexplained fatigue.
• Lipodystrophy: Changes in body fat distribution can occur with long-term antiretroviral therapy, including Zidovudine.

Patients should report any unusual or severe symptoms to their healthcare provider immediately.

Drug Interactions

Zidovudine can interact with other medications, potentially altering its effectiveness or increasing the risk of side effects. It is crucial to inform your doctor about all medications, supplements, and herbal products you are taking.

• Myelosuppressive Drugs: Co-administration with other drugs that suppress bone marrow function (e.g., ganciclovir, ribavirin, co-trimoxazole) can increase the risk of severe anemia or neutropenia.
• Stavudine: Zidovudine can antagonize the antiviral activity of stavudine, another NRTI, and their co-administration is generally not recommended.
• Probenecid: This drug can increase the blood levels of Zidovudine by inhibiting its renal excretion, potentially increasing the risk of toxicity.
• Phenytoin: Zidovudine may alter phenytoin levels, requiring monitoring of phenytoin concentrations.
• Other Antiretrovirals: Interactions can occur with certain other antiretroviral drugs, necessitating careful consideration of combination regimens.

Always consult with a healthcare professional before starting or stopping any medication while on Zidovudine therapy.

FAQ

Is Zidovudine a cure for HIV?

No, Zidovudine is not a cure for HIV. It is an antiretroviral medication that helps to control the virus, reduce viral load, and improve the immune system, but it does not eradicate HIV from the body.

Can Zidovudine be taken during pregnancy?

Yes, Zidovudine is a key component in preventing mother-to-child transmission of HIV and is safely used during pregnancy under medical supervision.

How long do I need to take Zidovudine?

For the treatment of HIV, Zidovudine is typically taken for life as part of a combination regimen. For prevention of mother-to-child transmission or post-exposure prophylaxis, the duration is specific and time-limited.

What should I do if I miss a dose?

If you miss a dose, take it as soon as you remember. However, if it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double up on doses.

What is AZT?

AZT is an acronym for azidothymidine, which is another name for Zidovudine.

Products containing Zidovudine are available through trusted online pharmacies. You can browse Zidovudine-based medications at ShipperVIP or Medicenter.

Summary

Zidovudine remains a historically significant and clinically important antiretroviral drug for the management of HIV-1 infection. As a nucleoside reverse transcriptase inhibitor, it effectively blocks viral replication, helping to control the disease, improve immune function, and prevent progression to AIDS. Its role in preventing mother-to-child transmission of HIV is particularly crucial. While effective, Zidovudine requires careful dosing, adherence to treatment regimens, and monitoring for potential side effects and drug interactions. Patients should always consult their healthcare provider for personalized advice and management of their HIV therapy.